3 exciting ASX small cap shares tipped for big things

If you’re a fan of small cap shares then you’re in luck because there are a good number of promising companies trading at the small end of the market right now.

Three small cap shares that I think are worth watching very closely are listed below. Here’s why I think they could be destined for big things:

Audinate (ASX: AD8)

Audinate is a provider of digital Audio-Visual networking technologies. The main product in its arsenal is the award-winning Dante audio over IP networking solution. The company has been experiencing exceptionally strong demand for Dante from professional live sound, commercial installation, broadcast, public address, and recording industries globally, leading to impressive sales growth. Although its recent third quarter result was a little disappointing, I think it is well worth keeping a close eye on its development. Especially with the company rolling out new product initiatives.

LiveTiles Ltd (ASX: LVT)

Another small cap tech share to watch is LiveTiles. It is a digital workplace platform provider and award-winning Microsoft Partner. Demand for its offering has been growing at an incredible rate in recent years, leading to stellar annualised recurring revenue (ARR) growth. This strong form has continued in FY 2019 with the company recently revealing that its ARR had more than tripled to $34.5 million at the end of the third quarter. Management isn’t resting on its laurels, though, and appears confident it can grow its ARR to $100 million by the end of June 2021.

Volpara Health Technologies Ltd (ASX: VHT)

One of my favourite small cap tech shares is Volpara Health Technologies. It is a medical technology company which provides increasingly popular software that uses AI imaging algorithms to assist in the early detection of breast cancer. It recently provided its full year update which revealed that its share of the U.S. breast screening market had grown to 7.1%. Pleasingly, more market share gains are expected in FY 2020 thanks to the quality of its product, the expansion of its salesforce, and recent favourable regulatory proposals.

Finally, here is another small cap share that has recently been rated as a buy and tipped for very big things.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click here to learn more on how you can profit from the coming cannabis boom.

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. The Motley Fool Australia has recommended VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019

Source link Finance News Australia

Enter your Email Address

Leave a Reply

Your email address will not be published. Required fields are marked *